AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 272: H797-H805, 1997;
0363-6135/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, R. P.
Right arrow Articles by Lakatta, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, R. P.
Right arrow Articles by Lakatta, E. G.

AJP - Heart and Circulatory Physiology, Vol 272, Issue 2 797-H805, Copyright © 1997 by American Physiological Society

ARTICLES

Opioid peptide receptor stimulation reverses beta-adrenergic effects in rat heart cells

R. P. Xiao, S. Pepe, H. A. Spurgeon, M. C. Capogrossi and E. G. Lakatta
Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, Baltimore, Maryland 21224, USA.

Opioid peptide receptor (OPR) agonists are co-released with the beta-adrenergic receptor (beta-AR) agonist norepinephrine (NE) from nerve terminals in the heart during sympathetic stimulation. Whereas recent studies indicate that OPR and beta-AR coexist on the surface of cardiac myocytes, whether significant "cross talk" occurs between OPR and beta-AR signaling cascades within heart cells is unknown. In the present study we demonstrate a marked effect of delta-OPR stimulation to modulate beta-adrenergic responses in single isolated rat ventricular myocytes. Nanomolar concentrations (10(-8) M) of the OPR agonist leucine enkephalin (LE), a naturally occurring delta-opioid peptide, inhibited NE-induced increases in sarcolemmal L-type Ca2+ current, cytosolic Ca2+ transient, and contraction. The antiadrenergic effect of LE was pertussis toxin sensitive and abolished by naloxone, an opioid receptor antagonist. In contrast, LE was unable to inhibit the positive inotropic effects induced by equipotent concentrations of 8-(4 chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, a cell-permeant adenosine 3',5'-cyclic monophosphate analog, or by the non-receptor-induced increase in contraction by elevated bathing Ca2+ concentration. These results indicate that an interaction of the OPR and beta-AR systems occurs proximal to activation of the adenosine 3',5'-cyclic monophosphate-dependent protein kinase of the beta-AR intracellular signaling pathway. This modulation of beta-adrenergic effects by OPR activation at the myocyte level may have important implications in the regulation of cardiac Ca2+ metabolism and contractility, particularly during the myocardial response to stress.


This article has been cited by other articles:


Home page
 Circ. Res.Home page
G. E. Breitwieser
G Protein-Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling
Circ. Res., January 9, 2004; 94(1): 17 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Coles Jr., D. C. Sigg, and P. A. Iaizzo
Role of kappa -opioid receptor activation in pharmacological preconditioning of swine
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2091 - H2099.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Y. Nakae, S. Fujita, and A. Namiki
Modulation of Myofilament Ca2+ Sensitivity by {delta}- and {kappa}-Opioid Agonists in Intact Guinea Pig Hearts
Anesth. Analg., March 1, 2003; 96(3): 733 - 739.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
T. P. Weber, C. Raufhake, M. A. Gro{beta}e Hartlage, N. Rolf, J. Stypmann, H. Van Aken, E. Berendes, and A. Mei{beta}ner
Naloxone prevents increased atrial natriuretic peptide release during regional myocardial ischaemia and stunning in awake dogs
Br. J. Anaesth., January 1, 2002; 88(1): 87 - 93.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
T. P. Weber, J. Stypmann, A. Mei{beta}ner, M. Gro{beta}e Hartlage, H. Van Aken, and N. Rolf
Naloxone improves functional recovery of myocardial stunning in conscious dogs through its action on the central nervous system
Br. J. Anaesth., April 1, 2001; 86(4): 545 - 549.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Younes, S. Pepe, B. A. Barron, H. A. Spurgeon, E. G. Lakatta, and J. L. Caffrey
Cardiac synthesis, processing, and coronary release of enkephalin-related peptides
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1989 - H1998.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. S. Jahania, J. A. Sanchez, P. Narayan, R. D. Lasley, and R. M. Mentzer Jr
Heart preservation for transplantation: principles and strategies
Ann. Thorac. Surg., November 1, 1999; 68(5): 1983 - 1987.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. J. Schultz, A. K. Hsu, H. Nagase, and G. J. Gross
TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels
Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H909 - H914.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. A. Jordan, N. Trapaidze, I. Gomes, R. Nivarthi, and L. A. Devi
Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation
PNAS, January 2, 2001; 98(1): 343 - 348.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online